|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of depreciable real estate | |||||
| Gain on sale of real estate | |||||
| Other non-cash expenses, net | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease in due from third party managers, net | |||||
| Decrease (increase) in other assets, net | |||||
| Increase in accounts payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of hotel properties, net | |||||
| Disbursements for potential acquisitions, net | |||||
| Capital improvements | |||||
| Net proceeds from sale of real estate | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (disbursements) proceeds related to issuance of common shares | |||||
| Repurchases of common shares | |||||
| Common shares surrendered to satisfy employee withholding requirements | |||||
| Distributions paid to common shareholders | |||||
| Proceeds from revolving credit facility | |||||
| Payments on revolving credit facility | |||||
| Proceeds from term loans and senior notes | |||||
| Payments on term loans and senior notes | |||||
| Payments of mortgage debt and other loans | |||||
| Principal payments on finance leases | |||||
| Financing costs | |||||
| Net cash used in financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flow information: | |||||
| Interest paid, net | |||||
| Income taxes paid | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Accrued distribution to common shareholders | |||||
| Accrued capital expenditures | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents, beginning of period | |||||
| Restricted cash-furniture, fixtures and other escrows, beginning of period | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Restricted cash-furniture, fixtures and other escrows, end of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
Loading...